Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Revenue:
Revenue		$ 1,199,654	$ 1,145,284
Net investment income		280,614	282,578
Realized gains (losses)		85	(11,799)
Other income		69	76
Total revenue		1,480,422	1,416,139
Benefits and expenses:
Total policyholder benefits		750,765	731,793
Amortization of deferred acquisition costs		105,515	99,478
Commissions, premium taxes, and non-deferred acquisition costs		164,323	148,110
Other operating expense		108,746	93,214
Interest expense		34,992	28,621
Total benefits and expenses		1,164,341	1,101,216
Income before income taxes		316,081	314,923
Income tax benefit (expense)		(61,518)	(60,706)
Net income		$ 254,563	$ 254,217
Basic net income per common share (in dollars per share)		$ 3.05	$ 2.71
Diluted net income per common share (in dollars per share)		$ 3.01	$ 2.67
Life Insurance
Revenue:
Revenue		$ 829,863	$ 804,265
Benefits and expenses:
Total policyholder benefits	[1]	509,756	519,871
Health Insurance
Revenue:
Revenue		369,791	341,019
Benefits and expenses:
Total policyholder benefits	[2]	233,929	202,327
Other
Benefits and expenses:
Total policyholder benefits		$ 7,080	$ 9,595

[1] Net of a remeasurement gain of $8.5 million for the three months ended March 31, 2025, and a remeasurement gain of $4.9 million for the same period in 2024.

[2] Net of a remeasurement gain of $444 thousand for the three months ended March 31, 2025 and a remeasurement gain of $3.2 million for the same period in 2024.